Evidence map›Paper›PMID 42225757›Full record

ArticleScientific reports2026

Effect of intratumoral alpha radiation on tumor growth delay and tumor microenvironment in an orthotopic colorectal liver metastasis murine model.

Oran Zlotnik, Anastasia Tsatoumas, Audrey Kapelanski-Lamoureux, Amatzia Gantz, Miran Rada, Stephanie K Petrillo, Jennifer Kalil, Shmuel Packer, Lisa Deutsch, Ronen Segal and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Oran ZlotnikCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Anastasia TsatoumasCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Audrey Kapelanski-LamoureuxCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Amatzia GantzCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Miran RadaCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Stephanie K PetrilloCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Jennifer KalilCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Shmuel PackerAlpha Tau Medical Ltd., Jerusalem, Israel.
Lisa DeutschBioStats Statistical Consulting Ltd, Maccabim, Israel.
Ronen SegalAlpha Tau Medical Ltd., Jerusalem, Israel.
Zu-Hua GaoDepartment of Pathology and Laboratory Medicine, University of British Columbia, Rm. G227-2211 Wesbrook Mall, Vancouver, BC, V6T 2B5, Canada.
Anthoula LazarisCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada.
Vered DomankevichAlpha Tau Medical Ltd., Jerusalem, Israel.
Peter MetrakosCancer Research Program, Research Institute, McGill University Health Centre, Montreal, QC, Canada. peter.metrakos@mcgill.ca.

Funding

MEDTEQ+ 17-C DaRT
6 · The paper itself

Abstract

Colorectal cancer frequently spreads to the liver, and current treatments often damage healthy liver tissue, while targeting tumors. Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) disperses alpha-emitting atoms from an intra-tumoral implanted source to a range of a few millimeters in the tumor. Alpha radiation is highly efficient in killing cancer cells, compared to other radiation types, and its short range in the tissue, potentially enables sparing healthy tissue adjacent to the tumor. Alpha DaRT's efficacy was previously demonstrated in subcutaneous tumors from various histotypes. Yet its effectiveness in treating tumors located in an internal organ, such as the liver, remains to be tested in animal studies. Here, we used a single liver metastasis orthotopic model by implanting MC38 colorectal metastatic tissue in mice livers. The metastasis was then treated either with a single radioactive or inert Alpha-DaRT source. Alpha-DaRT effectively delayed tumor growth without damaging the surrounding liver parenchymal tissue. F4/80 + immunosuppressive macrophages in the tumor-normal tissue interface were reduced following treatment. The findings suggest that this type of radiation therapy could be a promising option for treating patients with liver tumors.

Indexed as

Alpha ParticlesColorectal NeoplasmsLiver NeoplasmsTumor MicroenvironmentAnimalsCell Line, TumorDisease Models, AnimalFemaleHumansMacrophagesMiceAlpha DaRTAlpha particlesF4/80 + macrophagesLiver tumorsRadiation therapyRadium-224

Identifiers

PMID42225757
PMCPMC13458157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.